Organon (OGN) Enterprise Value (2020 - 2026)

Organon (OGN) has reported Enterprise Value for 7 consecutive years, with -$1.1 billion the latest figure, recorded in Q1 2026.

• In Q1 2026, Enterprise Value fell 104.02% year-over-year to -$1.1 billion; the TTM figure through Mar 2026 stood at -$1.1 billion (down 104.02% YoY), while the FY2025 annual figure was -$574.0 million, up 18.47% from the prior year.
• Enterprise Value came in at -$1.1 billion for Q1 2026 at Organon, down from -$574.0 million in the prior quarter.
• The five-year high for Enterprise Value was -$326.0 million in Q2 2023, with the low at -$1.1 billion in Q1 2026.
• Average Enterprise Value over 5 years is -$623.5 million, with a median of -$599.0 million recorded in 2025.
• The largest YoY upside for Enterprise Value was 50.5% in 2022 against a maximum downside of 392.2% in 2022.
• Year by year, Enterprise Value stood at -$706.0 million in 2022, then climbed by 0.57% to -$702.0 million in 2023, then dropped by 0.28% to -$704.0 million in 2024, then grew by 18.47% to -$574.0 million in 2025, then tumbled by 94.43% to -$1.1 billion in 2026.
• According to Business Quant data, Enterprise Value over the past three periods registered -$1.1 billion, -$574.0 million, and -$672.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.